deferoxamine has been researched along with Erythrocytosis in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BETETTO, D | 1 |
CRISTINA, P | 1 |
CAPPELLETTI, S | 1 |
FIELDING, J | 1 |
2 other studies available for deferoxamine and Erythrocytosis
Article | Year |
---|---|
[PRELIMINARY RESULTS ON THE USE OF DESFERRIOXAMINE IN POLYCYTHEMIA].
Topics: Alcoholism; Biomedical Research; Deferoxamine; Humans; Hydroxamic Acids; Iron; Liver Cirrhosis; Poly | 1963 |
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami | 1965 |